California State Teachers Retirement System (CalSTRS)’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-23,002
Closed -$80K 3322
2021
Q1
$80K Buy
23,002
+1,003
+5% +$4.07K ﹤0.01% 3068
2020
Q4
$74K Hold
21,999
﹤0.01% 3035
2020
Q3
$77K Buy
21,999
+629
+3% +$2.54K ﹤0.01% 2998
2020
Q2
$98K Hold
21,370
﹤0.01% 2952
2020
Q1
$71K Buy
21,370
+244
+1% +$1.12K ﹤0.01% 2875
2019
Q4
$129K Hold
21,126
﹤0.01% 2891
2019
Q3
$88K Hold
21,126
﹤0.01% 2954
2019
Q2
$277K Buy
+21,126
New +$259K ﹤0.01% 2701

Other funds holding PHAS

California State Teachers Retirement System (CalSTRS)'s PHAS Position: Q2 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q2 2021, closing a stake of 23,002 shares — an estimated $80K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in PHAS in Q2 2019 and held it in 8 quarters. The position peaked at $277K in Q2 2019. 55 funds tracked by Wall St. Rank hold PHAS as of Q2 2021.

  • California State Teachers Retirement System (CalSTRS) reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 23,002 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $80K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • California State Teachers Retirement System (CalSTRS)'s PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $277K in Q2 2019.
  • 55 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2021, filed 16 Aug 2021.